Back to homepage

Primary Care

Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Authors: Martina Burlando, Riccardo Castelli, Emanuele Cozzani, Aurora Parodi

Burlando M, Castelli R, Cozzani E, Parodi A. Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting. Drugs in Context 2021; 10: 2021-2-6. DOI: 10.7573/dic.2021-2-6

More▸

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis

Authors: Giovanna Malara, Gabriella Fabbrocini, Caterina Trifirò, Martina Burlando

The aim of the article is to describe a clinical experience aimed at increasing tolerability of dimethyl fumarate.

More▸

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Authors: Martina Burlando, Riccardo Castelli, Emanuele Cozzani, Aurora Parodi

This article reports experiences with tildrakizumab as they may be helpful to dermatologists to maximize the
efficiency of this therapy.

More▸

The multiple faces of ketamine in anaesthesia and analgesia

Authors: Silvia Natoli

This article provides information for the clinical use of ketamine in anaesthesia, in both conventional and special circumstances.

More▸

Tinea corporis: an updated review

Authors: Alexander KC Leung MBBS, FRCPC, FRCP (UK and Irel), FRCPCH, FAAP, Joseph M Lam MD, FRCPC, Kin Fon Leong MBBS, MRCPCH, Kam Lun Hon MD, FAAP, FCCM

This article provides a narrative updated review on the evaluation, diagnosis, and treatment of tinea corporis.

More▸